MNG
GILD icon

Manning & Napier Group’s Gilead Sciences GILD Stock Holding History

Manning & Napier Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$22.6M Sell
307,930
-26,410
-8% -$2.03M 0.26% 82
2023
Q4 		$27.1M Sell
334,340
-57,475
-15% -$4.47M 0.32% 74
2023
Q3 		$29.4M Sell
391,815
-5,359
-1% -$412K 0.36% 73
2023
Q2 		$30.6M Buy
397,174
+23,077
+6% +$1.84M 0.35% 75
2023
Q1 		$31M Sell
374,097
-692
-0.2% -$57.3K 0.36% 72
2022
Q4 		$32.2M Sell
374,789
-4,154
-1% -$329K 0.4% 66
2022
Q3 		$23.4M Sell
378,943
-5,066
-1% -$319K 0.31% 83
2022
Q2 		$23.7M Sell
384,009
-41,336
-10% -$2.56M 0.27% 83
2022
Q1 		$25.3M Sell
425,345
-28,726
-6% -$1.84M 0.24% 94
2021
Q4 		$33M Sell
454,071
-23,939
-5% -$1.65M 0.28% 90
2021
Q3 		$33.4M Sell
478,010
-8,147
-2% -$572K 0.29% 86
2021
Q2 		$33.5M Buy
486,157
+67,578
+16% +$4.51M 0.27% 92
2021
Q1 		$27.1M Buy
418,579
+9,711
+2% +$626K 0.23% 110
2020
Q4 		$23.8M Sell
408,868
-29,662
-7% -$1.79M 0.22% 112
2020
Q3 		$27.7M Sell
438,530
-3,100
-0.7% -$215K 0.28% 94
2020
Q2 		$34M Buy
441,630
+26,953
+6% +$2.07M 0.36% 74
2020
Q1 		$31M Sell
414,677
-37,816
-8% -$2.61M 0.37% 72
2019
Q4 		$29.4M Buy
452,493
+45,168
+11% +$2.94M 0.32% 82
2019
Q3 		$25.8M Buy
407,325
+2,928
+0.7% +$191K 0.29% 88
2019
Q2 		$27.3M Buy
404,397
+62,980
+18% +$4.14M 0.3% 86
2019
Q1 		$22.2M Buy
341,417
+67,924
+25% +$4.51M 0.24% 90
2018
Q4 		$17.1M Buy
273,493
+24,830
+10% +$1.74M 0.21% 97
2018
Q3 		$19.2M Buy
248,663
+15,062
+6% +$1.14M 0.19% 98
2018
Q2 		$16.5M Buy
233,601
+20,659
+10% +$1.46M 0.16% 100
2018
Q1 		$16.1M Buy
212,942
+39,383
+23% +$3.13M 0.16% 102
2017
Q4 		$12.4M Buy
+173,559
New +$13.2M 0.11% 108

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Manning & Napier Group's GILD Position: Q1 2024 in Review

Manning & Napier Group reduced its Gilead Sciences (GILD) stake by 7.9% in Q1 2024, selling an estimated $2.03M and leaving 307,930 shares worth $22.6M. The position accounts for 0.26% of the portfolio, ranked #82.

Manning & Napier Group first reported a position in GILD in Q4 2017 and has held it in 26 quarters since. The position peaked at $34M in Q2 2020. 1,725 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Manning & Napier Group held 307,930 shares of Gilead Sciences worth $22.6M as of Q1 2024.
  • Manning & Napier Group sold 26,410 Gilead Sciences shares in Q1 2024, an estimated $2.03M.
  • Gilead Sciences made up 0.26% of Manning & Napier Group's portfolio in Q1 2024, its #82 holding.
  • Manning & Napier Group first reported a position in Gilead Sciences in Q4 2017 and has held it in 26 quarters since.
  • Manning & Napier Group's Gilead Sciences position peaked at $34M in Q2 2020.
  • 1,725 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Manning & Napier Group's 13F filing for Q1 2024, filed 15 Apr 2024.